GSE224311 calcipotriol 3 v 0 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE224311_calcipotriol_3_v_0_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE224311_calcipotriol_3_v_0_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE224311_calcipotriol_3_v_0_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE224311_calcipotriol_3_v_0_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

FGD5 antisense RNA 1

Gene

CD27 antisense RNA 1

Gene

myocardial infarction associated transcript

Gene

uncharacterized LOC101928188

Gene

WNT5A antisense RNA 1

Gene

EMX2 opposite strand/antisense RNA

Gene

GAS1 adjacent regulatory RNA

Gene

myelodysplastic syndrome 2 translocation associated

Gene

CS pseudogene 2

Gene

long intergenic non-protein coding RNA 1730

  • Gene

    FGD5 antisense RNA 1


  • Gene

    CD27 antisense RNA 1


  • Gene

    myocardial infarction associated transcript


  • Gene

    uncharacterized LOC101928188


  • Gene

    WNT5A antisense RNA 1


  • Gene

    EMX2 opposite strand/antisense RNA


  • Gene

    GAS1 adjacent regulatory RNA


  • Gene

    myelodysplastic syndrome 2 translocation associated


  • Gene

    CS pseudogene 2


  • Gene

    long intergenic non-protein coding RNA 1730

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.